Pharmacovigilance as a key component of drug regulatory systems

Abstract

Information for control objects that are assigned risk categories is collected, processed, analyzed and recorded. The pharmaceutical manufacturer enters into an agreement with the recipient of the products on the exchange of data on the safety of such products in order to identify and study possible problems related to the safety of use, as well as to confirm social responsibility for the safety of drugs put into circulation.